Investor Presentaiton slide image

Investor Presentaiton

Key Ratios EBIT to Income EBITDA to Income Q1FY24 Q1FY23 PAT to Income 50.82% 35.10% 47.67% 44.35% 47.37% 32.61% SUVEN PHARMA
View entire presentation